Health Catalyst vs CoverMyMeds

Side-by-side comparison of AI visibility scores, market position, and capabilities

CoverMyMeds leads in AI visibility (90 vs 52)
Health Catalyst logo

Health Catalyst

ChallengerHealthcare

Data Analytics

$307M revenue 2024 (up from $296M 2023); $316M TTM Jun 2025; $26M adjusted EBITDA; 100M+ patient records; expects double-digit growth 2025; low-20s net new platform clients 2024; healthcare analytics leader

AI VisibilityBeta
Overall Score
C52
Category Rank
#1 of 1
AI Consensus
62%
Trend
stable
Per Platform
ChatGPT
53
Perplexity
46
Gemini
47

About

Health Catalyst is a healthcare data and analytics company founded in 2008 in Salt Lake City, Utah, built on the mission of being a catalyst for massive, measurable, data-informed improvement in the health of humanity. The company's core technology — the Health Catalyst Data Operating System (DOS) — provides healthcare organizations with a cloud-based data platform that aggregates clinical, financial, and operational data from disparate source systems into a unified analytics environment designed specifically for the complexity of healthcare data.\n\nHealth Catalyst serves 40+ health systems and hundreds of hospitals, offering analytics applications, embedded data science teams, and technology-enabled services that help organizations improve quality outcomes, reduce costs, and optimize operations. Its suite includes applications for perioperative efficiency, population health management, sepsis surveillance, and financial analytics. The company differentiates through a unique Tech-Enabled Managed Services model, embedding data scientists alongside health system teams to ensure analytics drive measurable operational change rather than sitting unused.\n\nHealth Catalyst generated $307M in revenue in 2024, up from $296M in 2023, with $26M in adjusted EBITDA and a database of over 100 million patient records. As a publicly traded company (HCAT), it has built one of the largest healthcare-specific analytics platforms in the US. With regulatory pressure, value-based care contracts, and margin compression intensifying across health systems, Health Catalyst's integrated data platform and domain expertise position it as a strategic partner for health systems pursuing data-driven operational transformation.

Full profile
CoverMyMeds logo

CoverMyMeds

LeaderHealthcare Revenue Cycle & Health IT

Prior Authorization & Medication Access

Largest prior authorization network in the US connecting 75K+ pharmacies, 750K+ providers, and all payers. Columbus OH; acquired by McKesson; available free to providers and pharmacies; processes millions of PA requests annually for specialty and retail prescriptions at no provider cost.

AI VisibilityBeta
Overall Score
A90
Category Rank
#1 of 1
AI Consensus
84%
Trend
up
Per Platform
ChatGPT
98
Perplexity
97
Gemini
92

About

CoverMyMeds is the largest prior authorization platform in the United States, operating a network that connects more than 750,000 providers, 75,000 pharmacies, and virtually all payers to streamline the authorization process for prescription medications. Founded in 2008 in Columbus, Ohio, and acquired by McKesson Corporation in 2017, CoverMyMeds processes millions of prior authorization requests annually and has become foundational infrastructure for the US pharmacy and specialty medication market. The platform is available at no cost to providers and pharmacies and is funded through health plan and PBM partnerships.\n\nCoverMyMeds' network effect is central to its value: because the platform is used by the vast majority of pharmacies and a very large share of prescribing providers, payers can reach their entire provider and pharmacy network through a single connection. The platform supports real-time benefit checks that show the formulary status and prior authorization requirements for a drug at the point of prescribing, enabling providers to make more informed prescribing decisions before a patient reaches the pharmacy counter. Automated electronic prior authorization (ePA) workflows reduce approval times from days to hours for eligible drug-payer combinations.\n\nAs part of McKesson, CoverMyMeds has expanded its capabilities to include specialty medication access solutions, patient assistance program enrollment, and medication adherence tools. The company's RxCrossroads subsidiary provides hub services for specialty pharmaceutical manufacturers, creating a comprehensive access ecosystem that spans from initial authorization through patient support and adherence management.

Full profile

AI Visibility Head-to-Head

52
Overall Score
90
#1
Category Rank
#1
62
AI Consensus
84
stable
Trend
up
53
ChatGPT
98
46
Perplexity
97
47
Gemini
92
60
Claude
94
45
Grok
93

Key Details

Category
Data Analytics
Prior Authorization & Medication Access
Tier
Challenger
Leader
Entity Type
brand
product

Capabilities & Ecosystem

Capabilities

Only Health Catalyst
Data Analytics
Only CoverMyMeds
Prior Authorization & Medication Access

Integrations

Only Health Catalyst
CoverMyMeds is classified as product (part of McKesson).

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.